Bradley’s Public Comment on the New DEA Teleprescribing Rules

New rules on prescribing controlled substances via telehealth threaten access to care for children and teenagers with ADHD.

“In our high-risk population, delays in obtaining appropriate medication can contribute to a life-threatening situation. When we prescribe stimulants to pediatric patients, they are always used under parental supervision.”

Read Bradley REACH’s public statement on the rule change below.

 
Previous
Previous

Clinical Director Outlines How to Talk to Your Teens Effectively.